The SELP, CD93, IL2RG, and VAV1 Genes Associated with Atherosclerosis May Be Potential Diagnostic Biomarkers for Psoriasis

References

• Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296(14):1735–1741. doi:10.1001/jama.296.14.1735
   PubMed Web of Science ®Google Scholar
• Armstrong EJ, Harskamp CT, Armstrong AW. Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies. J Am Heart Assoc. 2013;2(2):e000062. doi:10.1161/jaha.113.000062
   PubMed Web of Science ®Google Scholar
• Pietrzak A, Michalak-Stoma A, Chodorowska G, Szepietowski JC. Lipid disturbances in psoriasis: an update. Mediators Inflamm. 2010;2010:1–13. doi:10.1155/2010/535612
   Web of Science ®Google Scholar
• Miao C, Li J, Li Y, Zhang X. Obesity and dyslipidemia in patients with psoriasis: a case-control study. Medicine. 2019;98(31):e16323. doi:10.1097/md.0000000000016323
   Web of Science ®Google Scholar
• Lu H, Daugherty A. Atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35(3):485–491. doi:10.1161/atvbaha.115.305380
   PubMed Web of Science ®Google Scholar
• Masson W, Lobo M, Molinero G. Psoriasis and cardiovascular risk: a comprehensive review. Adv Ther. 2020;37(5):2017–2033. doi:10.1007/s12325-020-01346-6
   PubMed Web of Science ®Google Scholar
• Wang Y, Zang J, Liu C, Yan Z, Shi D. Interleukin-17 links inflammatory cross-talks between comorbid psoriasis and atherosclerosis. Front Immunol. 2022;13:835671. doi:10.3389/fimmu.2022.835671
   Web of Science ®Google Scholar
• Aksentijevich M, Lateef SS, Anzenberg P, Dey AK, Mehta NN. Chronic inflammation, cardiometabolic diseases and effects of treatment: psoriasis as a human model. Trends Cardiovasc Med. 2020;30(8):472–478. doi:10.1016/j.tcm.2019.11.001
   Web of Science ®Google Scholar
• Rose S, Stansky E, Dagur PK, et al. Characterization of immune cells in psoriatic adipose tissue. J Transl Med. 2014;12:258. doi:10.1186/s12967-014-0258-2
   Web of Science ®Google Scholar
• Ertenli I, Kiraz S, Arici M, et al. P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosis. J Rheumatol. 1998;25(6):1054–1058.
   PubMed Web of Science ®Google Scholar
• Burkhardt J, Blume M, Petit-Teixeira E, et al. Cellular adhesion gene SELP is associated with rheumatoid arthritis and displays differential allelic expression. PLoS One. 2014;9(8):e103872. doi:10.1371/journal.pone.0103872
   Web of Science ®Google Scholar
• George R, Bhatt A, Narayani J, Thulaseedharan JV, Sivadasanpillai H, Tharakan JA. Enhanced P-selectin expression on platelet-A marker of platelet activation, in young patients with angiographically proven coronary artery disease. Mol Cell Biochem. 2016;419(1–2):125–133. doi:10.1007/s11010-016-2756-4
   Web of Science ®Google Scholar
• Morris DL, Graham RR, Erwig LP, et al. Variation in the upstream region of P-Selectin (SELP) is a risk factor for SLE. Genes Immun. 2009;10(5):404–413. doi:10.1038/gene.2009.17
   Web of Science ®Google Scholar
• Zhang L, Chen S, Liu Y, et al. P-selectin blockade ameliorates lupus nephritis in MRL/lpr mice through improving renal hypoxia and evaluation using BOLD-MRI. J Transl Med. 2020;18(1):116. doi:10.1186/s12967-020-02284-1
   PubMed Web of Science ®Google Scholar
• Battistini L, Piccio L, Rossi B, et al. CD8+ T cells from patients with acute multiple sclerosis display selective increase of adhesiveness in brain venules: a critical role for P-selectin glycoprotein ligand-1. Blood. 2003;101(12):4775–4782. doi:10.1182/blood-2002-10-3309
   PubMed Web of Science ®Google Scholar
• Zhang N, Liu Z, Yao L, Mehta-D’souza P, McEver RP. P-selectin expressed by a human SELP transgene is atherogenic in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2016;36(6):1114–1121. doi:10.1161/atvbaha.116.307437
   Web of Science ®Google Scholar
• Ridker PM, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation. 2001;103(4):491–495. doi:10.1161/01.cir.103.4.491
   PubMed Web of Science ®Google Scholar
• Hillis GS, Terregino C, Taggart P, et al. Elevated soluble P-selectin levels are associated with an increased risk of early adverse events in patients with presumed myocardial ischemia. Am Heart J. 2002;143(2):235–241. doi:10.1067/mhj.2002.120303
   PubMed Web of Science ®Google Scholar
• Greenlee MC, Sullivan SA, Bohlson SS. Detection and characterization of soluble CD93 released during inflammation. Inflamm Res. 2009;58(12):909–919. doi:10.1007/s00011-009-0064-0
   Web of Science ®Google Scholar
• Greenlee-Wacker MC, Briseño C, Galvan M, Moriel G, Velázquez P, Bohlson SS. Membrane-associated CD93 regulates leukocyte migration and C1q-hemolytic activity during murine peritonitis. J Immunol. 2011;187(6):3353–3361. doi:10.4049/jimmunol.1100803
   Web of Science ®Google Scholar
• Greenlee MC, Sullivan SA, Bohlson SS. CD93 and related family members: their role in innate immunity. Curr Drug Targets. 2008;9(2):130–138. doi:10.2174/138945008783502421
   Web of Science ®Google Scholar
• Su C, Han Y, Qu B, et al. CD93 in macrophages: a novel target for atherosclerotic plaque imaging? J Cell Mol Med. 2022;26(8):2152–2162. doi:10.1111/jcmm.17237
   Web of Science ®Google Scholar
• Wang Y, Golden JB, Fritz Y, et al. Interleukin 6 regulates psoriasiform inflammation-associated thrombosis. JCI Insight. 2016;1(20):e89384. doi:10.1172/jci.insight.89384
   Web of Science ®Google Scholar
• Park HJ, Han H, Lee SC, et al. Soluble CD93 in serum as a marker of allergic inflammation. Yonsei Med J. 2017;58(3):598–603. doi:10.3349/ymj.2017.58.3.598
   Web of Science ®Google Scholar
• Jeon JW, Jung JG, Shin EC, et al. Soluble CD93 induces differentiation of monocytes and enhances TLR responses. J Immunol. 2010;185(8):4921–4927. doi:10.4049/jimmunol.0904011
   Web of Science ®Google Scholar
• Rahaman SO, Swat W, Febbraio M, Silverstein RL. Vav family Rho guanine nucleotide exchange factors regulate CD36-mediated macrophage foam cell formation. J Biol Chem. 2011;286(9):7010–7017. doi:10.1074/jbc.M110.192450
   Web of Science ®Google Scholar
• Bode AM, Dong Z. The functional contrariety of JNK. Mol Carcinog. 2007;46(8):591–598. doi:10.1002/mc.20348
   PubMed Web of Science ®Google Scholar
• Hammouda MB, Ford AE, Liu Y, Zhang JY. The JNK signaling pathway in inflammatory skin disorders and cancer. Cells. 2020;9(4):857. doi:10.3390/cells9040857
   PubMed Web of Science ®Google Scholar
• Guerreiro-Cacais AO, Norin U, Gyllenberg A, et al. VAV1 regulates experimental autoimmune arthritis and is associated with anti-CCP negative rheumatoid arthritis. Genes Immun. 2017;18(1):48–56. doi:10.1038/gene.2016.49
   PubMed Web of Science ®Google Scholar
• Maleknia S, Salehi Z, Rezaei Tabar V, Sharifi-Zarchi A, Kavousi K. An integrative Bayesian network approach to highlight key drivers in systemic lupus erythematosus. Arthritis Res Ther. 2020;22(1):156. doi:10.1186/s13075-020-02239-3
   Web of Science ®Google Scholar
• Jagodic M, Colacios C, Nohra R, et al. A role for VAV1 in experimental autoimmune encephalomyelitis and multiple sclerosis. Sci Transl Med. 2009;1(10):10ra21. doi:10.1126/scitranslmed.3000278
   PubMed Web of Science ®Google Scholar
• Ayars M, O’Sullivan E, Macgregor-Das A, et al. IL2RG, identified as overexpressed by RNA-seq profiling of pancreatic intraepithelial neoplasia, mediates pancreatic cancer growth. Oncotarget. 2017;8(48):83370–83383. doi:10.18632/oncotarget.19848
   PubMedGoogle Scholar
• Zhang LL, Pan HX, Wang YX, Guo T, Liu L. Genome profiling revealed the activation of IL2RG/JAK3/STAT5 in peripheral T‑cell lymphoma expressing the ITK‑SYK fusion gene. Int J Oncol. 2019;55(5):1077–1089. doi:10.3892/ijo.2019.4882
   Web of Science ®Google Scholar
• Kirken RA, Rui H, Malabarba MG, et al. Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain. Cytokine. 1995;7(7):689–700. doi:10.1006/cyto.1995.0081
   Web of Science ®Google Scholar
• Rujimongkon K, Ampawong S, Reamtong O, Buaban T, Aramwit P. The therapeutic effects of Bombyx mori sericin on rat skin psoriasis through modulated epidermal immunity and attenuated cell proliferation. J Tradit Complement Med. 2021;11(6):587–597. doi:10.1016/j.jtcme.2021.06.007
   Google Scholar
• Kyogoku C, Smiljanovic B, Grün JR, et al. Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference? PLoS One. 2013;8(12):e83776. doi:10.1371/journal.pone.0083776
   PubMed Web of Science ®Google Scholar
• Chang X, Yue L, Liu W, et al. CD38 and E2F transcription factor 2 have uniquely increased expression in rheumatoid arthritis synovial tissues. Clin Exp Immunol. 2014;176(2):222–231. doi:10.1111/cei.12268
   PubMed Web of Science ®Google Scholar
• Zhang R, Yang X, Wang J, et al. Identification of potential biomarkers for differential diagnosis between rheumatoid arthritis and osteoarthritis via integrative genome‑wide gene expression profiling analysis. Mol Med Rep. 2019;19(1):30–40. doi:10.3892/mmr.2018.9677
   PubMed Web of Science ®Google Scholar
• Pawlik A, Malinowski D, Paradowska-Gorycka A, Safranow K, Dziedziejko V. VAV1 gene polymorphisms in patients with rheumatoid arthritis. Int J Environ Res Public Health. 2020;17(9):3214. doi:10.3390/ijerph17093214
   Web of Science ®Google Scholar
• Feng ZW, Tang YC, Sheng XY, et al. Screening and identification of potential hub genes and immune cell infiltration in the synovial tissue of rheumatoid arthritis by bioinformatic approach. Heliyon. 2023;9(1):e12799. doi:10.1016/j.heliyon.2023.e12799
   Google Scholar
• Lowes MA, Suárez-Fariñas M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014;32:227–255. doi:10.1146/annurev-immunol-032713-120225
   PubMed Web of Science ®Google Scholar
• Chiricozzi A, Romanelli P, Volpe E, Borsellino G, Romanelli M. Scanning the Immunopathogenesis of Psoriasis. Int J Mol Sci. 2018;19(1):179. doi:10.3390/ijms19010179
   PubMed Web of Science ®Google Scholar
• Lorthois I, Asselineau D, Seyler N, Pouliot R. Contribution of in vivo and organotypic 3D models to understanding the role of macrophages and neutrophils in the pathogenesis of psoriasis. Mediators Inflamm. 2017;2017:7215072. doi:10.1155/2017/7215072
   PubMed Web of Science ®Google Scholar
• Kucuksezer UC, Aktas Cetin E, Esen F, et al. The role of natural killer cells in autoimmune diseases. Front Immunol. 2021;12:622306. doi:10.3389/fimmu.2021.622306
   PubMedGoogle Scholar
• Sajja AP, Joshi AA, Teague HL, Dey AK, Mehta NN. Potential immunological links between psoriasis and cardiovascular disease. Front Immunol. 2018;9:1234. doi:10.3389/fimmu.2018.01234
   PubMed Web of Science ®Google Scholar
• Yilmaz A, Lochno M, Traeg F, et al. Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis. 2004;176(1):101–110. doi:10.1016/j.atherosclerosis.2004.04.027
   PubMed Web of Science ®Google Scholar
• Li Y, Wang F, Imani S, Tao L, Deng Y, Cai Y. Natural killer cells: friend or foe in metabolic diseases? Front Immunol. 2021;12:614429. doi:10.3389/fimmu.2021.614429
   Google Scholar
• Harden JL, Krueger JG, Bowcock AM. The immunogenetics of Psoriasis: a comprehensive review. J Autoimmun. 2015;64:66–73. doi:10.1016/j.jaut.2015.07.008
   PubMed Web of Science ®Google Scholar
• Mabuchi T, Chang TW, Quinter S, Hwang ST. Chemokine receptors in the pathogenesis and therapy of psoriasis. J Dermatol Sci. 2012;65(1):4–11. doi:10.1016/j.jdermsci.2011.11.007
   PubMed Web of Science ®Google Scholar
• Zdanowska N, Kasprowicz-Furmańczyk M, Placek W, Owczarczyk-Saczonek A. the role of chemokines in psoriasis-an overview. Medicina. 2021;57(8):1. doi:10.3390/medicina57080754
   Google Scholar
• Zhang C, Yang M. The role and potential application of antimicrobial peptides in autoimmune diseases. Front Immunol. 2020;11:859. doi:10.3389/fimmu.2020.00859
   Web of Science ®Google Scholar
• Sato Y, Ogawa E, Okuyama R. Role of innate immune cells in psoriasis. Int J Mol Sci. 2020;21(18):6604. doi:10.3390/ijms21186604
   PubMed Web of Science ®Google Scholar
• Ottaviani C, Nasorri F, Bedini C, de Pità O, Girolomoni G, Cavani A. CD56brightCD16(-) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur J Immunol. 2006;36(1):118–128. doi:10.1002/eji.200535243
   PubMed Web of Science ®Google Scholar
• Han G, Williams CA, Salter K, Garl PJ, Li AG, Wang XJ. A role for TGFbeta signaling in the pathogenesis of psoriasis. J Invest Dermatol. 2010;130(2):371–377. doi:10.1038/jid.2009.252
   PubMed Web of Science ®Google Scholar
• Mangan PR, Harrington LE, O’Quinn DB, et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature. 2006;441(7090):231–234. doi:10.1038/nature04754
   PubMed Web of Science ®Google Scholar
• Pietrzak A, Chodorowska G, Szepietowski J, Zalewska-Janowska A, Krasowska D, Hercogová J. Psoriasis and serum lipid abnormalities. Dermatol Ther. 2010;23(2):160–173. doi:10.1111/j.1529-8019.2010.01311.x
   Web of Science ®Google Scholar
• Nowowiejska J, Baran A, Flisiak I. Aberrations in lipid expression and metabolism in psoriasis. Int J Mol Sci. 2021;22(12):6561. doi:10.3390/ijms22126561
   Web of Science ®Google Scholar
• Zeng C, Wen B, Hou G, et al. Lipidomics profiling reveals the role of glycerophospholipid metabolism in psoriasis. GigaScience. 2017;6(10):1–11. doi:10.1093/gigascience/gix087
   Web of Science ®Google Scholar
• Harada F, Uehara O, Morikawa T, et al. Effect of systemic administration of lipopolysaccharides derived from Porphyromonas gingivalis on gene expression in mice kidney. Med Mol Morphol. 2018;51(3):156–165. doi:10.1007/s00795-018-0181-3
   Web of Science ®Google Scholar
• Marques-Rocha JL, Samblas M, Milagro FI, Bressan J, Martínez JA, Marti A. Noncoding RNAs, cytokines, and inflammation-related diseases. FASEB J. 2015;29(9):3595–3611. doi:10.1096/fj.14-260323
   PubMed Web of Science ®Google Scholar
• Li M, Duan L, Li Y, Liu B. Long noncoding RNA/circular noncoding RNA-miRNA-mRNA axes in cardiovascular diseases. Life Sci. 2019;233:116440. doi:10.1016/j.lfs.2019.04.066
   PubMed Web of Science ®Google Scholar
• Haemmig S, Simion V, Yang D, Deng Y, Feinberg MW. Long noncoding RNAs in cardiovascular disease, diagnosis, and therapy. Curr Opin Cardiol. 2017;32(6):776–783. doi:10.1097/hco.0000000000000454
   PubMed Web of Science ®Google Scholar
• Chen YG, Satpathy AT, Chang HY. Gene regulation in the immune system by long noncoding RNAs. Nat Immunol. 2017;18(9):962–972. doi:10.1038/ni.3771
   PubMed Web of Science ®Google Scholar
• Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172(3):393–407. doi:10.1016/j.cell.2018.01.011
   PubMed Web of Science ®Google Scholar
• Tian X, Wu Y, Yang Y, et al. Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt/β-catenin signaling. Mol Oncol. 2020;14(2):462–483. doi:10.1002/1878-0261.12606
   PubMed Web of Science ®Google Scholar
• Lv X, Lian Y, Liu Z, Xiao J, Zhang D, Yin X. Exosomal long non-coding RNA LINC00662 promotes non-small cell lung cancer progression by miR-320d/E2F1 axis. Aging. 2021;13(4):6010–6024. doi:10.18632/aging.202522
   PubMedGoogle Scholar
• Wu GC, Pan HF, Leng RX, et al. Emerging role of long noncoding RNAs in autoimmune diseases. Autoimmun Rev. 2015;14(9):798–805. doi:10.1016/j.autrev.2015.05.004
   PubMed Web of Science ®Google Scholar